Novartis AG moves to dismiss US states' antitrust claims over generic drugs
MLex Summary: Novartis AG told a US judge that it doesn't belong in an antitrust case filed by a group of state attorneys general over an alleged generic drug pricing-fixing conspiracy,...To view the full article, register now.
Already a subscriber? Click here to view full article